GCTKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Glucotrack, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.68−0.04 (-5.56%)
Close on Oct 19, 2026
- Market cap
- $3.43M
- P/E (TTM)
- 0.0
- Dividend yield
- –
Share price
−$99.2103 (−99.31%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $3.43M
- P/E ratio
- 0.0
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -447.15%
Fundamentals
- Net income
- -$15.95M
- EPS, diluted
- $31.22
- Free cash flow
- -$15.34M
- Book value per share
- -$0.35
- Diluted shares
- 5M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$15.40M
Net income
-$15.95M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months